The following persons are apportioned baseline production allowances for HCFC-22, HCFC-141b, HCFC-142b, HCFC-123, HCFC-124, HCFC-225ca, and HCFC-225cb as set forth in the following table:

Person Controlled substance Allowances
AGC Chemicals Americas HCFC-225ca 266,608
HCFC-225cb 373,952
Arkema HCFC-22 46,692,336
HCFC-141b 24,647,925
HCFC-142b 484,369
DuPont HCFC-22 42,638,049
HCFC-124 2,269,210
Honeywell HCFC-22 37,378,252
HCFC-141b 28,705,200
HCFC-142b 2,417,534
HCFC-124 1,759,681
MDA Manufacturing HCFC-22 2,383,835
Solvay Specialty Polymers USA, LLC HCFC-142b 6,541,764

[79 FR 64287, Oct. 28, 2014]

Terms Used In 40 CFR 82.17

  • Baseline: Projection of the receipts, outlays, and other budget amounts that would ensue in the future without any change in existing policy. Baseline projections are used to gauge the extent to which proposed legislation, if enacted into law, would alter current spending and revenue levels.
  • Production: means the manufacture of a controlled substance from any raw material or feedstock chemical, but does not include:

    (1) The manufacture of a controlled substance that is subsequently transformed. See 40 CFR 82.3